Duramed (DRMD) Synthetic Estrogen Product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kevin kirkendall who started this subject	7/31/2000 5:09:23 PM
From: vestor	Read Replies (1) of 1837

DRMD's Cenestin 1.25 featured in Eckerd News publication, August 2000. Very positive article! Eckerd News is distributed to about 50,000 Eckerd Associates (employees). The article targets Eckerds pharmacists to alert customers. Some highlights of the artcle are: Cenestin 1.25 represents 19% of all scripts written. Cenestin is 20 to 27% below the cost of Premarin. I was alerted by a friend who works for them. He is bringing me a copy of the news letter. I will post further details as warranted after I see the hard copy.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next